Breast Implants and MCAS Insights with Surgeon Eva Nagy: MCAS Matters with Tania Dempsey, MD

In this podcast episode, Dr. Eva Nagy and Dr. Tania Dempsey discuss new findings related to Mast Cell Activation Syndrome (MCAS) and its potential role in Breast Implant Illness (BII). Dr. Nagy has published a study indicating that mast cells may play a key role in BII, as evidenced by the significant symptom reduction post-explant surgery and the presence of mast cells in excised tissue. The discussion highlights that even if breast implants seem intact, the body's response can lead to systemic symptoms. Removal of both the implants and surrounding capsule tissue appears crucial for symptom resolution, with most patients experiencing significant improvement. The episode stresses the importance of careful consideration before opting for breast implants, especially for those with known MCAS or other immune-related conditions. Dr. Nagy also emphasizes the importance of complete capsule removal to prevent ongoing immune activation, and the challenges faced in surgery when implants have led to complex health issues.